Supplementary tables. It includes all supplementary tables. Table S1.List of 114 cancer-related genes. Table S2. Summary of the 33 cancer types. Table S3. Summary of the reported 33 genes involved in 77 events of tumor-specific cleavage patterns. Table S4. Details of all CSs involved in the reported 77 APA events. Table S5. Mapping relations between diseases in TCGA and those in COSMIC (Supplementary Methods). (XLSX 235 kb
List of the MAFs used in the analysis. Table S2. List of 999 batch-biased variants in TCGA data. Tab...
Table S1. Clinical features of two EAC molecular subtypes. Table S2. Differentially expressed genes ...
This file contains supplementary Figure S9. Numbers of genes containing SNVs leading to AASs in canc...
Supplementary figures. It includes all supplementary figures except Figure S4. Figure S1. Benchmark ...
Table S1. Systems-level properties of cancer genes. Table S2 List of 273 publications describing can...
Figure S4. Illustration of all 77 identified events of tumor-specific cleavage patterns. (PDF 5699 k...
Supplementary tables. Table S1. Cancer genes in detected amplification regions. Table S2. Cancer gen...
Table S1. 48 genes included in the TruSeq Amplicon Cancer Panel (TSACP, Illumina), which includes 21...
Table S1. List of the relative abundance of all histone peptides. Table S2. List of the relative abu...
Table S1. contains the list of the genes used in the study, as well as indicators for which pathway ...
All supplementary tables merged. 1: List of all identified SiMPRes. 2: All novel genes that contain ...
Sequences of the primers used for Sanger sequencing. Table S2. Comprehensive list of variants from t...
This file contains Tables S1 to S9. Microsoft Excel Workbook containing 6 worksheets. Table S1: Vari...
Supplementary methods, use cases description, Table S2. and Figures S1âS3. (PDF 6267 kb
Supplementary Tables. Table S1 lists the number of SNV and indel mutations found in each individual ...
List of the MAFs used in the analysis. Table S2. List of 999 batch-biased variants in TCGA data. Tab...
Table S1. Clinical features of two EAC molecular subtypes. Table S2. Differentially expressed genes ...
This file contains supplementary Figure S9. Numbers of genes containing SNVs leading to AASs in canc...
Supplementary figures. It includes all supplementary figures except Figure S4. Figure S1. Benchmark ...
Table S1. Systems-level properties of cancer genes. Table S2 List of 273 publications describing can...
Figure S4. Illustration of all 77 identified events of tumor-specific cleavage patterns. (PDF 5699 k...
Supplementary tables. Table S1. Cancer genes in detected amplification regions. Table S2. Cancer gen...
Table S1. 48 genes included in the TruSeq Amplicon Cancer Panel (TSACP, Illumina), which includes 21...
Table S1. List of the relative abundance of all histone peptides. Table S2. List of the relative abu...
Table S1. contains the list of the genes used in the study, as well as indicators for which pathway ...
All supplementary tables merged. 1: List of all identified SiMPRes. 2: All novel genes that contain ...
Sequences of the primers used for Sanger sequencing. Table S2. Comprehensive list of variants from t...
This file contains Tables S1 to S9. Microsoft Excel Workbook containing 6 worksheets. Table S1: Vari...
Supplementary methods, use cases description, Table S2. and Figures S1âS3. (PDF 6267 kb
Supplementary Tables. Table S1 lists the number of SNV and indel mutations found in each individual ...
List of the MAFs used in the analysis. Table S2. List of 999 batch-biased variants in TCGA data. Tab...
Table S1. Clinical features of two EAC molecular subtypes. Table S2. Differentially expressed genes ...
This file contains supplementary Figure S9. Numbers of genes containing SNVs leading to AASs in canc...